VigiBase, the Glossary
VigiBase is a World Health Organization's (WHO) global Individual Case Safety Report (ICSR) database that contains ICSRs submitted by the participating member states enrolled under WHO's international drug monitoring programme.[1]
Table of Contents
27 relations: Adverse drug reaction, Allopathic medicine, Clinical trial, Competent authority, Council for International Organizations of Medical Sciences, Drug development, EudraVigilance, Geneva, Health authority, International Classification of Diseases, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, International Society of Pharmacovigilance, MedDRA, Medical device, Open Database Connectivity, Pharmacovigilance, Relational database, Society of Pharmacovigilance, India, SQL, Sweden, Thalidomide, Uppsala, Uppsala Monitoring Centre, Vaccine, WHOART, World Health Organization, Yellow Card Scheme.
- Pharmacological classification systems
- Pharmacovigilance databases
Adverse drug reaction
An adverse drug reaction (ADR) is a harmful, unintended result caused by taking medication.
See VigiBase and Adverse drug reaction
Allopathic medicine
Allopathic medicine, or allopathy, is an archaic and derogatory label originally used by 19th-century homeopaths to describe heroic medicine, the precursor of modern evidence-based medicine.
See VigiBase and Allopathic medicine
Clinical trial
Clinical trials are prospective biomedical or behavioral research studies on human participants designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison.
See VigiBase and Clinical trial
A competent authority is any person or organization that has the legally delegated or invested authority, capacity, or power to perform a designated function.
See VigiBase and Competent authority
Council for International Organizations of Medical Sciences
The Council for International Organizations of Medical Sciences (CIOMS) is an international non-governmental organization of 40 international, national, and associate member groups representing the biomedical science community. VigiBase and Council for International Organizations of Medical Sciences are pharmaceuticals policy.
See VigiBase and Council for International Organizations of Medical Sciences
Drug development
Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery.
See VigiBase and Drug development
EudraVigilance
EudraVigilance (European Union Drug Regulating Authorities Pharmacovigilance) is the European data processing network and management system for reporting and evaluation of suspected adverse reactions to medicines which have been authorised or being studied in clinical trials in the European Economic Area (EEA). VigiBase and EudraVigilance are pharmaceuticals policy and pharmacovigilance databases.
See VigiBase and EudraVigilance
Geneva
Geneva (Genève)Genf; Ginevra; Genevra.
Health authority
Between 1996 and 2002, the National Health Service in England and Wales was organised under health authorities (HAs).
See VigiBase and Health authority
International Classification of Diseases
The International Classification of Diseases (ICD) is a globally used medical classification used in epidemiology, health management and for clinical purposes. VigiBase and International Classification of Diseases are World Health Organization.
See VigiBase and International Classification of Diseases
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is an initiative that brings together regulatory authorities and pharmaceutical industry to discuss scientific and technical aspects of pharmaceutical product development and registration. VigiBase and International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use are pharmaceuticals policy.
International Society of Pharmacovigilance
The International Society of Pharmacovigilance (ISoP), previously the European Society of Pharmacovigilance (ESOP), is an international non-profit scientific organisation, which aims to foster pharmacovigilance both scientifically and educationally, and enhance all aspects of the safe and proper use of medicines, in all countries. VigiBase and international Society of Pharmacovigilance are pharmaceuticals policy.
See VigiBase and International Society of Pharmacovigilance
MedDRA
A subscription-based product of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), MedDRA or Medical Dictionary for Regulatory Activities is a clinically validated international medical terminology dictionary-thesaurus used by regulatory authorities and the biopharmaceutical industry during the regulatory process, from pre-marketing (clinical research phase 0 to phase 3) to post-marketing activities (pharmacovigilance or clinical research phase 4), and for safety information data entry, retrieval, evaluation, and presentation. VigiBase and MedDRA are Pharmacological classification systems.
Medical device
A medical device is any device intended to be used for medical purposes.
See VigiBase and Medical device
Open Database Connectivity
In computing, Open Database Connectivity (ODBC) is a standard application programming interface (API) for accessing database management systems (DBMS).
See VigiBase and Open Database Connectivity
Pharmacovigilance
Pharmacovigilance (PV, or PhV), also known as drug safety, is the pharmaceutical science relating to the "collection, detection, assessment, monitoring, and prevention" of adverse effects with pharmaceutical products. VigiBase and Pharmacovigilance are pharmaceuticals policy.
See VigiBase and Pharmacovigilance
Relational database
A relational database (RDB) is a database based on the relational model of data, as proposed by E. F. Codd in 1970.
See VigiBase and Relational database
Society of Pharmacovigilance, India
The Society of Pharmacovigilance, India (SoPI), is an Indian national non-profit scientific organisation, which aims at organizing training programmes and providing expertise in pharmacovigilance and enhance all aspects of the safe and proper use of medicines The International Society of Pharmacovigilance (ISoP) granted status of 'associated society' to Society of Pharmacovigilance India (SoPI). VigiBase and society of Pharmacovigilance, India are pharmaceuticals policy and Pharmacological classification systems.
See VigiBase and Society of Pharmacovigilance, India
SQL
Structured Query Language (SQL) (pronounced S-Q-L; historically "sequel") is a domain-specific language used to manage data, especially in a relational database management system (RDBMS).
See VigiBase and SQL
Sweden
Sweden, formally the Kingdom of Sweden, is a Nordic country located on the Scandinavian Peninsula in Northern Europe.
Thalidomide
Thalidomide, sold under the brand names Contergan and Thalomid among others, is an oral medication used to treat a number of cancers (e.g., multiple myeloma), graft-versus-host disease, and many skin disorders (e.g., complications of leprosy such as skin lesions).
Uppsala
Uppsala (archaically spelled Upsala) is the county seat of Uppsala County and the fourth-largest city in Sweden, after Stockholm, Gothenburg, and Malmö.
Uppsala Monitoring Centre
Uppsala Monitoring Centre (UMC), located in Uppsala, Sweden, is the field name for the World Health Organization Collaborating Centre for International Drug Monitoring. VigiBase and Uppsala Monitoring Centre are international medical and health organizations, organizations established in 1978, pharmaceuticals policy and World Health Organization.
See VigiBase and Uppsala Monitoring Centre
Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease.
WHOART
The WHO Adverse Reactions Terminology (WHOART) was a dictionary meant to serve as a basis for rational coding of adverse reaction terms. VigiBase and WHOART are Pharmacological classification systems.
World Health Organization
The World Health Organization (WHO) is a specialized agency of the United Nations responsible for international public health. VigiBase and World Health Organization are international medical and health organizations.
See VigiBase and World Health Organization
Yellow Card Scheme
The Yellow Card Scheme is the United Kingdom's system for collecting information on suspected adverse drug reactions (ADRs) to medicines. VigiBase and Yellow Card Scheme are pharmaceuticals policy.
See VigiBase and Yellow Card Scheme
See also
Pharmacological classification systems
- ATC codes
- Anatomical Therapeutic Chemical Classification System
- Australian Approved Name
- Bencao Gangmu
- Biopharmaceutics Classification System
- Brazilian Nonproprietary Name
- British Approved Name
- COSTART
- Classification of Pharmaco-Therapeutic Referrals
- Dénomination Commune Française
- Denominazione Comune Italiana
- Drug class
- Drug identification number
- Drug nomenclature
- Formulary (pharmacy)
- Generally recognized as safe and effective
- Generic Product Identifier
- Guide to Pharmacology
- Japanese Accepted Name
- MedDRA
- National Pharmaceutical Product Index
- National drug code
- Pharmaceutical code
- Pregnancy category
- Prototype drug
- RxNorm
- Society of Pharmacovigilance, India
- Unique Ingredient Identifier
- United States Adopted Name
- VigiBase
- WHO Drug Dictionary
- WHOART
Pharmacovigilance databases
- EudraVigilance
- FDA Adverse Event Reporting System
- Farmacovigilancia Española, Datos de Reacciones Adversas
- Japanese Adverse Drug Event Report database
- Vaccine Adverse Event Reporting System
- VigiBase